Encore Medical Gains FDA Approval for Ceramic Hip Implant

Encore Medical have just received pre-market approval from the US Food and Drug Administration (FDA) for their ceramic-on-ceramic acetabular hip replacement.

Encore’s new offering is marketed under the name Keramos and is suited to younger more active patients as it has improved longer term performance, reducing the likelihood of the need for revision surgery, especially when compared to polymeric (polyethylene) and metallic implants.

The Keramos range of implants use alumina as the ceramic material. The new ceramic-on-ceramic system adds to current offerings of ceramic-on-polyethylene, metal-on-polyethylene and metal-on-metal systems.

For more information on hip replacements, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.